Current status of treatment for primary effusion lymphoma.

Okada S, Goto H, Yotsumoto M

Intractable Rare Dis Res. 2014; 3(3):65-74.

DOI: 10.5582/irdr.2014.01010

Summary Full Text (PDF)

Pseudoxanthoma elasticum: A review of 86 cases in China.

Li Y, Cui YZ, Zhao H, Wang C, Liu X, Han JX

Intractable Rare Dis Res. 2014; 3(3):75-78.

DOI: 10.5582/irdr.2014.01011

Summary Full Text (PDF)

An overview of Korean patients with mucopolysaccharidosis and collaboration through the Asia Pacific MPS Network.

Cho SY, Sohn YB, Jin DK

Intractable Rare Dis Res. 2014; 3(3):79-86.

DOI: 10.5582/irdr.2014.01013

Summary Full Text (PDF)

Noninvasive prenatal testing in China: Future detection of rare genetic diseases?

Mei L, Tang Q, Sun BY, Xu LZ

Intractable Rare Dis Res. 2014; 3(3):87-90.

DOI: 10.5582/irdr.2014.01012

Summary Full Text (PDF)

Current research on pycnodysostosis.

Turan S

Intractable Rare Dis Res. 2014; 3(3):91-93.

DOI: 10.5582/irdr.2014.01014

Summary Full Text (PDF)

The Ice Bucket Challenge: The public sector should get ready to promptly promote the sustained development of a system of medical care for and research into rare diseases.

Song PP

Intractable Rare Dis Res. 2014; 3(3):94-96.

DOI: 10.5582/irdr.2014.01015

Summary Full Text (PDF)

Amniotic Fluid Embolism (AFE) in China: Are maternal mortality and morbidity preventable?

Mo XT, Feng AH, Liu XY, Tobe RG

Intractable Rare Dis Res. 2014; 3(3):97-99.

DOI: 10.5582/irdr.2014.01016

Summary Full Text (PDF)